Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.
Researching New Drugs "Needs Research into New Pricing Systems"
March 31st 2015In yet another demonstration of how far drug pricing concerns are invading the hitherto sacrosanct territory of drug development, a consortium of national advisory bodies on pricing have written to the chief official responsible for European Union drug research.
Changing the Context of European Pharma
February 26th 2015It seems only yesterday that the future for European pharma was personalized medicine. The European Union first gave the term official status in a formal paper in 2008, entitled a Renewed Vision for the Pharmaceutical Sector, in which the Commission included a section on ‘Towards more personalized medicines’.
Catching Up With Data Disclosure
March 31st 2014With the European Union's new rules on clinical trials?including data access?approaching their final legislative stage, and the European Medicines Agency planning to announce its new rules on data disclosure within weeks, the European drug industry is still running to catch up with transparency issues.